Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AXITINIB vs AZELNIDIPINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AXITINIB vs AZELNIDIPINE: Safety Overview

Metric AXITINIB AZELNIDIPINE
Total FAERS Reports 15,863 126
Deaths Reported 3,141 7
Death Rate 19.8% 5.6%
Hospitalizations 4,050 85
Average Patient Age 65.5 yrs 64.6 yrs
% Female Patients 29.4% 64.5%
FDA Approval Date Jan 27, 2012 N/A
Manufacturer Pfizer Laboratories Div Pfizer Inc N/A
Route ORAL N/A
Marketing Status Prescription N/A